A Chinese biotechnological company announced that it has developed the world's first 3D blood vessel bio-printer, which makes it possible to produce personalised functional organs, the media reported on Monday.
Sichuan Revotek Co. Ltd., based in Chengdu, on Sunday said the significant breakthrough has been achieved through its self-developed stem cell bio-ink technology, 3D bio-printer and cloud computing platform, the China Daily reported.
"The creative breakthrough in the 3D blood vessel bio-printing means we have mastered the stem cell-based 3D bio-printing technology," said Yang Keng, the company chairman said.
Blood vessels that transport nutrients to organs are indispensable elements when creating any organs, according to James Kang, an expert who led the programme.
Kang's team has created a novel type of bio-ink - "Biosynsphere", whose primary goal is the personalised stem cell bio-printing to pave the way for organ regeneration.
"We have successfully realized the blood vessel regeneration by relying on the 3D bio-printer, the biosynsphere technology and the data model based on cloud computing," he said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
